SlideShare una empresa de Scribd logo
1 de 37
Descargar para leer sin conexión
NSAIDs
(non steroidal anti-
inflammatory drugs)
   Biol 4407/Bioc 4806.5/
   Nesc 4376/PHC 5409B
              Dr.T.C. Peterson
THE INFLAMMATORY
    RESPONSE

1. The inflammatory response is a normal
(desirable) defense mechanism.
2. The side effects are undesirable.
3. Normal inflammatory response has an on/
off switch.
4. In chronic inflammation something has
gone wrong with the OFF switch
5. Therefore we need drugs to control the
inflammatory reaction.
Mediators of the
    inflammatory response

Complement system
histamine
serotonin
bradykinin - major contributors to symptoms of inflammation
leukotrienes - increase vascular permeability
            - increase mobilization of endogenous mediators of inflammation
prostaglandins PGE2 ‑ promote edema and leukocyte infiltration
                PGI2 ‑ increase vascular permeability, enhance pain producing
                         properties of bradykinin
INFLAMMATORY SITE


Sensitized lymphocytes release soluble factors ( which
  recruit & mobilize macrophages to the inflammed tissue.)

Additional activated macrophages produce enhanced levels of
  enzymes and mediators

Thereby involving macrophages in the defense against
  microorganisms and foreign antigens

BUT remember that the inflammatory cells have the
  potential to destroy surrounding tissue.
Mediators of
inflammation
4 signs of inflammation

Redness - due to local vessel dilatation
Heat - due to local vessel dilatation
Swelling – due to influx of plasma
proteins and phagocytic cells into the
tissue spaces
Pain – due to local release of enzymes
and increased tissue pressure
Major pathways
Eicosanoids
Eicosanoids – a family of compounds that are
  the products of three main pathways which
  use oxygen as a major cosubstrate.
The three pathways are:
  the cyclooxygenase pathway
  the lipoxygenase pathway
  the epoxygenase pathway.
COX 1 and COX 2
The key enzyme in the
cyclooxygenase pathway is the
enzyme cyclooxygenase (COX).

There are two forms of cyclooxygenase,
COX1 (the predominant form) and
COX2.
ANTI‑ INFLAMMATORY
         DRUGS

 salicylates e.g., ASA
phenylpropionic acids e.g., ibuprofen,
ketoprofen
pyrazalone derivatives e.g., phenylbutazone
indole derivatives e.g., indomethacin
Remission inducing / disease modifying
drugs: e.g. chloroquine, aurothioglucose,
penicillamine, prednisolone
Prostaglandin inhibitory
activity correlates to anti-
   inflammatory effect
MECHANISM OF ACTION

Non-steroidal anti-inflammatory drugs (NSAIDs)
  All NSAIDs inhibit the cyclooxygenase required for
  conversion of arachidonic acid to endoperoxide
  intermediate (PGG2 and PGH2).
  NSAIDs inhibit prostaglandin and thromboxane synthesis,
  they are potent inhibitors of cyclooxygenase and eliminate
  all prostaglandins and thromboxanes in every cell they
  reach
  Recall that prostaglandins and thromboxanes play crucial
  roles in: Pain, Inflammation, Fever , Excessive blood
  clotting
Nsaial
Salicylate structure
Pyrazolone structure
Indole structure
Nsaial
Due to the adverse effects of Aspirin (esp. GI and
antiplatelet), many newer NSAIDS have been developed.

Ibuprofen: PROPIONIC ACID DERIVATIVE
-same potency as ASA .
-better tolerated (fewer side effects)
 -ex. Advil; Motrin
Available over the counter (OTC)

Indomethacin: INDOLE DERIVATIVE
-more potent than ASA but inferior at doses tolerated by
rheumatoid arthritis patients.
-quite toxic
-PDA
Phenylbutazone:
PYRAZOLONE DERIVATIVE
-powerful anti-inflammatory drug
-usefulness is limited by its toxicity
-chiefly short-term therapy

Piroxicam:
-half-life = 45 hours
-administer once a day ( increased convenience)
-some GI disturbance
Sulindac:
-inactive pro-drug closely related to indomethacin
-must be metabolized by hepatic microsomal enzymes to
active form
-long duration of action (half-life = 8h)
-adverse effects less severe than other NSAIDS (ex. GI
and renal)
-ex. Clinoril

Ketoprofen:
-inhibits both cyclooxygenase and lipoxygenase
(decreases PGs, TXs, and LTs)
*recall LTs: bronchospam;bronchoconstriction
-may be desirable for asthmatics or inflammation plus
allergic response
-ex.Orudis
Nsaial
COX-2 INHIBITORS

Cyclooxygenase-1 (COX-1):
-constitutively expressed in wide variety of cells
all over the body.
-"housekeeping enzyme"
-ex. gastric cytoprotection, hemostasis

Cyclooxygenase-2 (COX-2):
-inducible enzyme
-immediate-early gene product in inflammatory
and immune cells
-dramatically up-regulated during inflammation
(10-18X)
Adverse effects of NSAIDS are theorized to be due to
inhibition of COX-1 (ex. GI complications via decreased
PGE2 and potentially altered blood flow)

In some instances cytoprotectives e.g., misoprostol (PGE2
analogue) may be taken with NSAIDS to reduce GI effects.


Selective COX-2 inhibitors were developed
e.g., Celecoxib (Celebrex); Roficoxib (Vioxx) which was
withdrawn in 2004 due to serious CV effects and in Sept.
2007 Merck agreed to pay 4.8 billion dollars settlement.
Nitric Oxide-Releasing NSAIDS      NO-NSAIDS

Less GI effects than parent NSAID from which
they are derived.

Comparable anti-inflammatory effect and superior
analgesic effect

Example: NO-naproxen
      Parent NSAID: naproxen

Possible mechanism: nitric oxide would improve
gastric blood flow
Nsaial
DIETARY MANIPULATION OF
           INFLAMMATION
Arachidonic Acid (AA) -eicosatetraenoic acid (4 double bonds)

Eicosapentaenoic acid (EPA) -5 double bonds
EPA
EPA is found in fish oil

It acts as a substrate for cyclooxygenases and
lipoxygenases (thus it competes with arachidonic acid
for the enzymes)

The prostaglandins, thromboxanes, and leukotrienes
produced from EPA are less active than AA
metabolites.
EPA      continued

These products can then compete with products of AA
metabolism for shared target receptors.

Macrophages with a high content of EPA produce less
TNF and IL-l (key pro-inflammatory cytokines)

Thus,
• Dietary EPA supplementation can reduce tissue
injury due to PGs, TXs, LTs, and cytokines!!
EPA       continued

Clinical studies have shown decreased morning stiffness
and joint pain in rheumatoid arthritis patients with EPA
supplementation

Potency approximates NSAIDS, with negligible side
effects!!
Inflammatory events in
     the gouty joint
GOUTY ARTHRITIS:
    inflammatory mechanism
Body fluids supersaturate with urate and urate
  crystals precipitate in tissues.
  Resulting in pain and inflammation
Phagocytosis of crystals by polymorphs and the
migration of leukocytes to the inflamed area
  Release inflammatory mediators into joint
ANTI-INFLAMMATORY DRUGS
  AND GOUTY ARTHRITIS
Colchicine
indomethacin
adrenal steroids
new NSAIDS e.g. sulindac (acute gout)
probenecid, sulfinpyrazone
allopurinol
Nsaial
Mechanism of action of
      Allopurinol
  Allopurinol inhibits synthesis of uric acid by
  competing for the enzyme xanthine oxidase.

Hypoxanthine   xanthine oxidase   xanthine   xanthine oxidase Uric
                                                              acid


Allopurinol xanthine oxidase Alloxanthine
Glucocorticoids

- inhibit phagocytosis
- inhibit synthesis of IL‑1, TNF, PGs LTs.
- inhibit antigen processing by
macrophages
- stabilizes lysosomal membranes
- inhibits accumulation of neutrophils and
  monocytes at inflammation site.
- inhibit phospholipase A2.
Glucocorticoids

  examples: prednisone
              dexamethasone
Side effects:
  osteoporosis
  impaired wound healing
  edema, hypertension, congestive heart failure
CNS effects (euphoria ‑ psychosis)
Cushingoid Syndrome
Nsaial

Más contenido relacionado

La actualidad más candente

La actualidad más candente (20)

Cox 2 inhibitors
Cox 2 inhibitorsCox 2 inhibitors
Cox 2 inhibitors
 
Opioid analgesics pharmacology
Opioid analgesics pharmacologyOpioid analgesics pharmacology
Opioid analgesics pharmacology
 
NonSteroidal Anti-Inflammatory Drugs (NSAIDs)
NonSteroidal Anti-Inflammatory Drugs (NSAIDs)NonSteroidal Anti-Inflammatory Drugs (NSAIDs)
NonSteroidal Anti-Inflammatory Drugs (NSAIDs)
 
Non steroidal antiinflammatory drugs
Non steroidal antiinflammatory drugsNon steroidal antiinflammatory drugs
Non steroidal antiinflammatory drugs
 
NSAIDs
NSAIDsNSAIDs
NSAIDs
 
Pharmacology of NSAIDs (Non-Steroidal Anti-Inflammatory Drugs (Dr. Sohail Ahmad)
Pharmacology of NSAIDs (Non-Steroidal Anti-Inflammatory Drugs (Dr. Sohail Ahmad)Pharmacology of NSAIDs (Non-Steroidal Anti-Inflammatory Drugs (Dr. Sohail Ahmad)
Pharmacology of NSAIDs (Non-Steroidal Anti-Inflammatory Drugs (Dr. Sohail Ahmad)
 
Endo-_CORTICOSTEROIDS.pdf
Endo-_CORTICOSTEROIDS.pdfEndo-_CORTICOSTEROIDS.pdf
Endo-_CORTICOSTEROIDS.pdf
 
NSAIDs
NSAIDsNSAIDs
NSAIDs
 
NSAIDS
 NSAIDS NSAIDS
NSAIDS
 
Analgesics
AnalgesicsAnalgesics
Analgesics
 
Pharmacotherapy of Pain
Pharmacotherapy of PainPharmacotherapy of Pain
Pharmacotherapy of Pain
 
NSAIDs- Non Steroid Anti Inflammatory Drugs
NSAIDs- Non Steroid Anti Inflammatory Drugs NSAIDs- Non Steroid Anti Inflammatory Drugs
NSAIDs- Non Steroid Anti Inflammatory Drugs
 
EICOSANOIDS
EICOSANOIDSEICOSANOIDS
EICOSANOIDS
 
Nsaid ppt
Nsaid pptNsaid ppt
Nsaid ppt
 
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
 
12.drugs used in rheumatoid arthritis and gout
12.drugs used in rheumatoid arthritis and gout 12.drugs used in rheumatoid arthritis and gout
12.drugs used in rheumatoid arthritis and gout
 
Drugs used in treatment of rheumatoid arthiritis
Drugs used in treatment of rheumatoid arthiritisDrugs used in treatment of rheumatoid arthiritis
Drugs used in treatment of rheumatoid arthiritis
 
NSAIDs
NSAIDsNSAIDs
NSAIDs
 
NSAIDS
NSAIDSNSAIDS
NSAIDS
 
10.nsai ds
10.nsai ds 10.nsai ds
10.nsai ds
 

Similar a Nsaial

Anti rheumatic drug ( NSAIDs and DMARDs )
Anti rheumatic drug ( NSAIDs and DMARDs )Anti rheumatic drug ( NSAIDs and DMARDs )
Anti rheumatic drug ( NSAIDs and DMARDs )EL Sayed Sabry
 
NSAIDs in Periodontology
NSAIDs in PeriodontologyNSAIDs in Periodontology
NSAIDs in PeriodontologyShilpa Shiv
 
Analgesics.pptx
Analgesics.pptxAnalgesics.pptx
Analgesics.pptxeyobkaseye
 
COX Inhibitors. Non-Steroid Anti-inflammatory Drugs
COX Inhibitors. Non-Steroid Anti-inflammatory DrugsCOX Inhibitors. Non-Steroid Anti-inflammatory Drugs
COX Inhibitors. Non-Steroid Anti-inflammatory DrugsEneutron
 
Ocular NSAIDs and Steroids
Ocular NSAIDs and SteroidsOcular NSAIDs and Steroids
Ocular NSAIDs and SteroidsAayush Chandan
 
ROLE OF ANTI-INFLAMMATORY DRUGS IN SURGERY
ROLE OF ANTI-INFLAMMATORY DRUGS  IN  SURGERYROLE OF ANTI-INFLAMMATORY DRUGS  IN  SURGERY
ROLE OF ANTI-INFLAMMATORY DRUGS IN SURGERYDR AMEER HAMZA
 
anti inflammatory drugs
anti inflammatory drugsanti inflammatory drugs
anti inflammatory drugsdosemanju
 
lec-3 Analgesics.pptx
lec-3 Analgesics.pptxlec-3 Analgesics.pptx
lec-3 Analgesics.pptxhaimn
 
Non Steroidal Anti Inflammatory Drugs
Non Steroidal Anti Inflammatory DrugsNon Steroidal Anti Inflammatory Drugs
Non Steroidal Anti Inflammatory DrugsDr Rayan Malick
 
Non-steroidal anti-inflammatory drugs (NSAIDs)
Non-steroidal anti-inflammatory drugs (NSAIDs)Non-steroidal anti-inflammatory drugs (NSAIDs)
Non-steroidal anti-inflammatory drugs (NSAIDs)Ravish Yadav
 
Non narcotic analgesics .pptx
Non narcotic analgesics .pptxNon narcotic analgesics .pptx
Non narcotic analgesics .pptxPraveen kumar S
 
Antipyretic, analgesic
Antipyretic,  analgesicAntipyretic,  analgesic
Antipyretic, analgesicMrunalAkre
 

Similar a Nsaial (20)

NSAID's
NSAID's NSAID's
NSAID's
 
Anti rheumatic drug ( NSAIDs and DMARDs )
Anti rheumatic drug ( NSAIDs and DMARDs )Anti rheumatic drug ( NSAIDs and DMARDs )
Anti rheumatic drug ( NSAIDs and DMARDs )
 
Nsaids
NsaidsNsaids
Nsaids
 
NSAIDs in Periodontology
NSAIDs in PeriodontologyNSAIDs in Periodontology
NSAIDs in Periodontology
 
Ocular nsaids s
Ocular nsaids sOcular nsaids s
Ocular nsaids s
 
Analgesics.pptx
Analgesics.pptxAnalgesics.pptx
Analgesics.pptx
 
COX Inhibitors. Non-Steroid Anti-inflammatory Drugs
COX Inhibitors. Non-Steroid Anti-inflammatory DrugsCOX Inhibitors. Non-Steroid Anti-inflammatory Drugs
COX Inhibitors. Non-Steroid Anti-inflammatory Drugs
 
Ocular NSAIDs and Steroids
Ocular NSAIDs and SteroidsOcular NSAIDs and Steroids
Ocular NSAIDs and Steroids
 
ROLE OF ANTI-INFLAMMATORY DRUGS IN SURGERY
ROLE OF ANTI-INFLAMMATORY DRUGS  IN  SURGERYROLE OF ANTI-INFLAMMATORY DRUGS  IN  SURGERY
ROLE OF ANTI-INFLAMMATORY DRUGS IN SURGERY
 
anti inflammatory drugs
anti inflammatory drugsanti inflammatory drugs
anti inflammatory drugs
 
Cox inhibitor
Cox inhibitorCox inhibitor
Cox inhibitor
 
lec-3 Analgesics.pptx
lec-3 Analgesics.pptxlec-3 Analgesics.pptx
lec-3 Analgesics.pptx
 
ROLE OF NON STEROIDAL ANTI- INFLAMMATORY DRUGS IN PERIODONTICS.pptx
ROLE OF NON STEROIDAL ANTI- INFLAMMATORY DRUGS IN PERIODONTICS.pptxROLE OF NON STEROIDAL ANTI- INFLAMMATORY DRUGS IN PERIODONTICS.pptx
ROLE OF NON STEROIDAL ANTI- INFLAMMATORY DRUGS IN PERIODONTICS.pptx
 
Non Steroidal Anti Inflammatory Drugs
Non Steroidal Anti Inflammatory DrugsNon Steroidal Anti Inflammatory Drugs
Non Steroidal Anti Inflammatory Drugs
 
Non-steroidal anti-inflammatory drugs (NSAIDs)
Non-steroidal anti-inflammatory drugs (NSAIDs)Non-steroidal anti-inflammatory drugs (NSAIDs)
Non-steroidal anti-inflammatory drugs (NSAIDs)
 
NSAIDs.pptx
NSAIDs.pptxNSAIDs.pptx
NSAIDs.pptx
 
Non narcotic analgesics .pptx
Non narcotic analgesics .pptxNon narcotic analgesics .pptx
Non narcotic analgesics .pptx
 
e. NSADIs.pdf
e. NSADIs.pdfe. NSADIs.pdf
e. NSADIs.pdf
 
NSAIDs (VK)
NSAIDs (VK)NSAIDs (VK)
NSAIDs (VK)
 
Antipyretic, analgesic
Antipyretic,  analgesicAntipyretic,  analgesic
Antipyretic, analgesic
 

Más de Flavio Guzmán (20)

Ops
OpsOps
Ops
 
Pk2
Pk2Pk2
Pk2
 
Pk2
Pk2Pk2
Pk2
 
Kinetika En 2002
Kinetika En 2002Kinetika En 2002
Kinetika En 2002
 
Pk1 Ppt
Pk1 PptPk1 Ppt
Pk1 Ppt
 
Kinetika En 2002
Kinetika En 2002Kinetika En 2002
Kinetika En 2002
 
Ceorins
CeorinsCeorins
Ceorins
 
AUPDATE
AUPDATEAUPDATE
AUPDATE
 
05052008OvarianTelehealth
05052008OvarianTelehealth05052008OvarianTelehealth
05052008OvarianTelehealth
 
mati
matimati
mati
 
DrTerespolsky
DrTerespolskyDrTerespolsky
DrTerespolsky
 
15
1515
15
 
gopalan031607
gopalan031607gopalan031607
gopalan031607
 
IncidentalomaTalk
IncidentalomaTalkIncidentalomaTalk
IncidentalomaTalk
 
Nikiforov
NikiforovNikiforov
Nikiforov
 
Thpt
ThptThpt
Thpt
 
Thyroid Disease
Thyroid DiseaseThyroid Disease
Thyroid Disease
 
THYCER
THYCERTHYCER
THYCER
 
DrRobertFoxUtahSSF
DrRobertFoxUtahSSFDrRobertFoxUtahSSF
DrRobertFoxUtahSSF
 
Sjögren's_syndrome~_Role_for_Cevimeline
Sjögren's_syndrome~_Role_for_CevimelineSjögren's_syndrome~_Role_for_Cevimeline
Sjögren's_syndrome~_Role_for_Cevimeline
 

Último

SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfSGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfHongBiThi1
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...Shubhanshu Gaurav
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024EwoutSteyerberg1
 
Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfMedicoseAcademics
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondSujoy Dasgupta
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu Medical University
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Vaikunthan Rajaratnam
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communicationskatiequigley33
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.pptRamDBawankar1
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionkrishnareddy157915
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfDolisha Warbi
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfDolisha Warbi
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxNaveenkumar267201
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaSujoy Dasgupta
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.aarjukhadka22
 

Último (20)

SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfSGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024
 
Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdf
 
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and Beyond
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu
 
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communications
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung function
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
 
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
 
American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...
 

Nsaial

  • 1. NSAIDs (non steroidal anti- inflammatory drugs) Biol 4407/Bioc 4806.5/ Nesc 4376/PHC 5409B Dr.T.C. Peterson
  • 2. THE INFLAMMATORY RESPONSE 1. The inflammatory response is a normal (desirable) defense mechanism. 2. The side effects are undesirable. 3. Normal inflammatory response has an on/ off switch. 4. In chronic inflammation something has gone wrong with the OFF switch 5. Therefore we need drugs to control the inflammatory reaction.
  • 3. Mediators of the inflammatory response Complement system histamine serotonin bradykinin - major contributors to symptoms of inflammation leukotrienes - increase vascular permeability - increase mobilization of endogenous mediators of inflammation prostaglandins PGE2 ‑ promote edema and leukocyte infiltration PGI2 ‑ increase vascular permeability, enhance pain producing properties of bradykinin
  • 4. INFLAMMATORY SITE Sensitized lymphocytes release soluble factors ( which recruit & mobilize macrophages to the inflammed tissue.) Additional activated macrophages produce enhanced levels of enzymes and mediators Thereby involving macrophages in the defense against microorganisms and foreign antigens BUT remember that the inflammatory cells have the potential to destroy surrounding tissue.
  • 6. 4 signs of inflammation Redness - due to local vessel dilatation Heat - due to local vessel dilatation Swelling – due to influx of plasma proteins and phagocytic cells into the tissue spaces Pain – due to local release of enzymes and increased tissue pressure
  • 8. Eicosanoids Eicosanoids – a family of compounds that are the products of three main pathways which use oxygen as a major cosubstrate. The three pathways are: the cyclooxygenase pathway the lipoxygenase pathway the epoxygenase pathway.
  • 9. COX 1 and COX 2 The key enzyme in the cyclooxygenase pathway is the enzyme cyclooxygenase (COX). There are two forms of cyclooxygenase, COX1 (the predominant form) and COX2.
  • 10. ANTI‑ INFLAMMATORY DRUGS  salicylates e.g., ASA phenylpropionic acids e.g., ibuprofen, ketoprofen pyrazalone derivatives e.g., phenylbutazone indole derivatives e.g., indomethacin Remission inducing / disease modifying drugs: e.g. chloroquine, aurothioglucose, penicillamine, prednisolone
  • 11. Prostaglandin inhibitory activity correlates to anti- inflammatory effect
  • 12. MECHANISM OF ACTION Non-steroidal anti-inflammatory drugs (NSAIDs) All NSAIDs inhibit the cyclooxygenase required for conversion of arachidonic acid to endoperoxide intermediate (PGG2 and PGH2). NSAIDs inhibit prostaglandin and thromboxane synthesis, they are potent inhibitors of cyclooxygenase and eliminate all prostaglandins and thromboxanes in every cell they reach Recall that prostaglandins and thromboxanes play crucial roles in: Pain, Inflammation, Fever , Excessive blood clotting
  • 18. Due to the adverse effects of Aspirin (esp. GI and antiplatelet), many newer NSAIDS have been developed. Ibuprofen: PROPIONIC ACID DERIVATIVE -same potency as ASA . -better tolerated (fewer side effects) -ex. Advil; Motrin Available over the counter (OTC) Indomethacin: INDOLE DERIVATIVE -more potent than ASA but inferior at doses tolerated by rheumatoid arthritis patients. -quite toxic -PDA
  • 19. Phenylbutazone: PYRAZOLONE DERIVATIVE -powerful anti-inflammatory drug -usefulness is limited by its toxicity -chiefly short-term therapy Piroxicam: -half-life = 45 hours -administer once a day ( increased convenience) -some GI disturbance
  • 20. Sulindac: -inactive pro-drug closely related to indomethacin -must be metabolized by hepatic microsomal enzymes to active form -long duration of action (half-life = 8h) -adverse effects less severe than other NSAIDS (ex. GI and renal) -ex. Clinoril Ketoprofen: -inhibits both cyclooxygenase and lipoxygenase (decreases PGs, TXs, and LTs) *recall LTs: bronchospam;bronchoconstriction -may be desirable for asthmatics or inflammation plus allergic response -ex.Orudis
  • 22. COX-2 INHIBITORS Cyclooxygenase-1 (COX-1): -constitutively expressed in wide variety of cells all over the body. -"housekeeping enzyme" -ex. gastric cytoprotection, hemostasis Cyclooxygenase-2 (COX-2): -inducible enzyme -immediate-early gene product in inflammatory and immune cells -dramatically up-regulated during inflammation (10-18X)
  • 23. Adverse effects of NSAIDS are theorized to be due to inhibition of COX-1 (ex. GI complications via decreased PGE2 and potentially altered blood flow) In some instances cytoprotectives e.g., misoprostol (PGE2 analogue) may be taken with NSAIDS to reduce GI effects. Selective COX-2 inhibitors were developed e.g., Celecoxib (Celebrex); Roficoxib (Vioxx) which was withdrawn in 2004 due to serious CV effects and in Sept. 2007 Merck agreed to pay 4.8 billion dollars settlement.
  • 24. Nitric Oxide-Releasing NSAIDS NO-NSAIDS Less GI effects than parent NSAID from which they are derived. Comparable anti-inflammatory effect and superior analgesic effect Example: NO-naproxen Parent NSAID: naproxen Possible mechanism: nitric oxide would improve gastric blood flow
  • 26. DIETARY MANIPULATION OF INFLAMMATION Arachidonic Acid (AA) -eicosatetraenoic acid (4 double bonds) Eicosapentaenoic acid (EPA) -5 double bonds
  • 27. EPA EPA is found in fish oil It acts as a substrate for cyclooxygenases and lipoxygenases (thus it competes with arachidonic acid for the enzymes) The prostaglandins, thromboxanes, and leukotrienes produced from EPA are less active than AA metabolites.
  • 28. EPA continued These products can then compete with products of AA metabolism for shared target receptors. Macrophages with a high content of EPA produce less TNF and IL-l (key pro-inflammatory cytokines) Thus, • Dietary EPA supplementation can reduce tissue injury due to PGs, TXs, LTs, and cytokines!!
  • 29. EPA continued Clinical studies have shown decreased morning stiffness and joint pain in rheumatoid arthritis patients with EPA supplementation Potency approximates NSAIDS, with negligible side effects!!
  • 30. Inflammatory events in the gouty joint
  • 31. GOUTY ARTHRITIS: inflammatory mechanism Body fluids supersaturate with urate and urate crystals precipitate in tissues. Resulting in pain and inflammation Phagocytosis of crystals by polymorphs and the migration of leukocytes to the inflamed area Release inflammatory mediators into joint
  • 32. ANTI-INFLAMMATORY DRUGS AND GOUTY ARTHRITIS Colchicine indomethacin adrenal steroids new NSAIDS e.g. sulindac (acute gout) probenecid, sulfinpyrazone allopurinol
  • 34. Mechanism of action of Allopurinol Allopurinol inhibits synthesis of uric acid by competing for the enzyme xanthine oxidase. Hypoxanthine xanthine oxidase xanthine xanthine oxidase Uric acid Allopurinol xanthine oxidase Alloxanthine
  • 35. Glucocorticoids - inhibit phagocytosis - inhibit synthesis of IL‑1, TNF, PGs LTs. - inhibit antigen processing by macrophages - stabilizes lysosomal membranes - inhibits accumulation of neutrophils and monocytes at inflammation site. - inhibit phospholipase A2.
  • 36. Glucocorticoids examples: prednisone dexamethasone Side effects: osteoporosis impaired wound healing edema, hypertension, congestive heart failure CNS effects (euphoria ‑ psychosis) Cushingoid Syndrome